ArticleInternational journal of surgery case reports2026
Descemet stripping endothelial keratoplasty following simple limbal epithelial transplantation for chemical injury-related endothelial dysfunction: two case reports.
Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Ocular chemical injury primarily results in corneal epithelial damage and limbal stem cell deficiency (LSCD), leading to delayed epithelial healing and recurrent epithelial breakdowns. Simple limbal epithelial transplantation (SLET) is the most promising surgical modality for the treatment of unilateral LSCD, helping restore and stabilize the ocular surface. However, in some instances, chemical injury can also result in corneal endothelial damage. This under-recognized entity can mimic SLET failure, leading to delayed or inappropriate management. Case presentation: We describe two patients with chemical injury-induced LSCD who were initially managed with SLET and subsequently developed persistent corneal edema and recurrent epithelial breakdowns. Despite the stable SLET transplants, the recurrent epithelial defects and non-resolving corneal edema raised the suspicion of an underlying endothelial dysfunction. Anterior segment optical coherence tomography (AS-OCT) revealed increased corneal thickness, Descemet membrane irregularity and undulations; and endothelial excrescences. Both patients underwent Descemet stripping automated endothelial keratoplasty (DSAEK). At the final follow-up, both patients demonstrated significant improvement in visual acuity, with a stable epithelial surface and compact cornea. Clinical discussion: Endothelial dysfunction can clinically resemble SLET failure due to overlapping features such as epithelial breakdown, corneal edema, scarring, and vascularization. Anterior segment Optical Coherence Tomography (AS-OCT) is a valuable diagnostic tool when specular microscopy is not feasible, as it can demonstrate features of endothelial dysfunction. Sequential management with initial ocular surface stabilization using SLET followed by endothelial keratoplasty, can achieve favorable outcome in selected cases with minimal underlying corneal scarring. Conclusion: Endothelial dysfunction following chemical injury is frequently overlooked due to compromised visualization of the anterior chamber from the overlying corneal pannus, stromal scarring, and ocular surface inflammation. Early recognition of endothelial involvement is essential. A staged surgical approach, with initial ocular surface reconstruction followed by endothelial keratoplasty, can optimize visual and anatomical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.